US2022111389A1PendingUtilityA1

Sample preparation device

Assignee: ALERE SAN DIEGO INCPriority: Nov 5, 2015Filed: Nov 1, 2021Published: Apr 14, 2022
Est. expiryNov 5, 2035(~9.3 yrs left)· nominal 20-yr term from priority
C12Q 1/6848C12Q 1/6806B01D 15/12B01L 3/567B01J 20/291F04B 9/14B01L 2200/0631C12Q 1/6844B01L 2200/12B01D 15/34F04B 53/10B01L 7/52B01L 2300/0854B01L 2300/0832G01N 1/14G01N 30/20F04B 13/00G01N 2030/027B01L 3/0217B01L 2200/0684G01N 2030/143G01N 2030/062B01L 3/502B01L 2400/0487B01L 2200/0621F04B 9/12G01N 30/02B01L 2400/0478G01N 30/06B01L 2300/069B01L 2400/065B01L 2300/14G01N 30/14G01N 1/4005B01L 2200/0605B01L 3/0293G01N 30/48G01N 2030/486
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A manually actuated chromatography device comprising a chamber for receiving a liquid sample, a pump with a metering valve, and a chromatography element, wherein the pump moves a predetermined volume of liquid from the sample chamber to the chromatography element.

Claims

exact text as granted — not AI-modified
1 . A method for performing an isothermal nucleic acid amplification comprising:
 providing a raw liquid sample;   processing the raw liquid sample to remove nucleic acid amplification inhibiting agents and/or fluorescent agents;   performing an isothermal nucleic acid amplification on the processed sample; and
 monitoring for amplified nucleic acid. 
   
     
     
         2 . The method according to  claim 1  wherein the processing step comprises using size exclusion chromatography. 
     
     
         3 . The method according to  claim 1  further comprising contacting the raw liquid sample to a lytic agent prior to processing the raw liquid sample. 
     
     
         4 . The method according to  claim 1  further comprising buffering the raw liquid sample. 
     
     
         5 . The method according to  claim 1  wherein the raw liquid sample is selected from the group consisting of urine, blood, plasma, serum, saliva, cerebrospinal fluid, and tear fluid. 
     
     
         6 . The method according to  claim 1  wherein the raw liquid sample is an elute from a vaginal, nasal, throat, penile, anal, or skin swab. 
     
     
         7 . The method of  claim 1  further comprising buffering the raw liquid sample during processing the raw liquid sample. 
     
     
         8 . The method according to  claim 1  wherein processing the raw liquid sample comprises providing a manually actuated chromatography device comprising a chamber for receiving a liquid sample, a pump with a metering valve, and a chromatography element. 
     
     
         9 . The method of  claim 8  wherein the manually actuated chromatography device comprises a first part and a separate second part receivable in the first part. 
     
     
         10 . The method of  claim 9  further comprising receiving, in the first part, the second part. 
     
     
         11 . The method of  claim 10  comprising actuating the pump by the second part of the manually actuated chromatography device operably engaging the first part of manually actuated chromatography device. 
     
     
         12 . The method of  claim 8 , wherein the pump moves a predetermined volume of liquid from the chamber to the chromatography element. 
     
     
         13 . The method of  claim 8 , wherein the manually actuated chromatography device is a single-use device. 
     
     
         14 . The method of  claim 8 , wherein the device is actuatable by a single movement. 
     
     
         15 . The method of  claim 14 , wherein said single movement is a push or rotation. 
     
     
         16 . The method of  claim 1 , wherein processing the raw liquid sample is completed in less than 10 minutes. 
     
     
         17 . The method of  claim 1 , wherein processing the raw liquid sample is completed in less than 3 minutes. 
     
     
         18 . The method of  claim 12 , wherein said predetermined volume of liquid is 0.5 to 1.0 milliliters. 
     
     
         19 . The method of  claim 1 , wherein said isothermal nucleic acid amplification is a recombinase polymerase amplification (RPA) or nicking and extension amplification reaction (NEAR). 
     
     
         20 . The method of  claim 1 , wherein the method is performed at the point of care.

Join the waitlist — get patent alerts

Track US2022111389A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.